Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Classificação em ações #96
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Preço da ação
$43.92
Última sincronização: 2026-09-11
Valor de mercado
$195.10B
Variação (1 dia)
-3.37%
Variação (1 ano)
-17.97%
País
DK
Negociar Novo Nordisk A/S (NOVO-B)

Categoria

Histórico de preços das ações de Novo Nordisk A/S (NOVO-B)
Preço de fecho mais alto: $45.23 em 2026-09-01

Preço de fecho mais baixo: $6.85 em 2010-02-01
Histórico de preços das ações da Novo Nordisk A/S de 2010 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -3.05%
2025 -51.49%
2024 1.66%
2023 53.39%
2022 17.33%
2021 57.90%
2020 22.88%
2019 26.30%
2018 -13.92%
2017 49.76%
2016 -37.96%
2015 26.26%
2014 24.70%
2013 10.83%
2012 43.56%
2011 6.06%
2010 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$1.11K 47.49%
US
$265.87 49.31%
US
$257.01 17.71%
US
$459.10 30.72%
CH
$144.05 73.95%
US